Company description

Mon, 16 Mar 2026 21:17:29 GMT

Headquartered in Markham, Ontario, iFabric, www.ifabriccorp.com, is listed on the TSX and, currently has 30.3 million shares issued and outstanding. Its two strategic divisions offer a variety of products and services through wholly-owned subsidiaries, namely, Intelligent Fabric Technologies (North America) Inc. ("IFTNA") and Coconut Grove Pads Inc. ("Coconut Grove").

IFTNA is focused on development and sale of high-performance sports apparel, medical protective apparel, consumer protective apparel, and proprietary treatments that provide "intelligent" properties to fabrics, foams, plastics, and numerous other surfaces, thereby improving the safety and well-being of the user. Such intelligent properties include antiviral and antibacterial characteristics, water-repellence and UV protection, among others.

Research

Mon, 16 Mar 2026 14:26:28 GMT

Ifabric Corp. (OTC:IFABF) (TSX:IFA) (C$2.22; C$67.3M market cap) announced estimated fiscal 2025 revenue and preliminary Q1 2026 revenue outlook:

Fiscal 2025 revenue estimated at approximately $33 million, representing about 20% year-over-year growth and a new 12-month company record.
Q1 2026 revenue expected between $20 million and $25 million, compared with $7.1 million in Q1 2025.
Growth driven primarily by expansion of clinically-proven medical scrubs programs and Intelligent Fabric Technologies category expansion.
Company expects scrubs programs and category expansion initiatives to support continued revenue growth through 2026 and 2027.
Company provided targeted inventory clearance support in Q4 2025 to help retailers transition from competing brands into iFabric branded programs.
Majority of prior Maidenform licensed revenue has been replaced with revenue from the company’s own brand platform targeting a younger demographic.

Management Commentary:

"Fiscal 2025 ended with real acceleration for iFabric," said Hylton Karon, President & CEO of iFabric Corp. "Our record fourth quarter revenue of approximately $11 million was not an isolated event. It reflects the strength of programs we built throughout 2025, and that momentum has rolled directly into 2026. We are entering this year with a broader platform, stronger retail reach, and more growth drivers than at any point in our history," concluded Hylton Karon

“The Company also highlighted the exceptional start to fiscal 2026. Dependent on shipping dates, revenue for Q1 2026 is currently expected to be in the range of $20 million to $25 million, making it the largest ever quarter in corporate history. Management noted that this increase is being driven by expansion of existing, new and re-branded programs. In certain cases, iFabric provided targeted inventory clearance support in Q4 2025 to help major retailers transition from competing brands into Company branded programs. This is a short-term investment the Company believes is positioning it for significant longer-term gains.”

"The speed at which our clinically-proven scrubs programs have scaled gives us a high level of confidence in the size of the opportunity ahead," added Mr. Karon. "Those programs are expanding quickly, our order book remains strong, and IFTNA is continuing to open doors in new product categories. We believe that momentum will continue through 2026 and well into 2027," concluded Mr. Karon.

“The Company added that its transition away from the prior Maidenform license is substantially reshaping its intimate apparel business. iFabric has already replaced the majority of the revenue previously generated from Maidenform licensed products with revenue from its own brand platform, geared toward a younger and better-aligned demographic. Management believes its new brand platform not only replaces the prior licensed revenue stream, but also creates materially broader opportunities in product development, positioning, and market expansion than would have been available under the Maidenform brand.”

Our Quick Take:

iFabric is clearly guiding toward a very strong Q1 2026, driven primarily by its clinically proven medical scrubs. In a previous interview (October 8, 2025), management stated that the scrubs category could generate C$20–C$30M in revenue over the next two to three years. The current guidance, along with management’s outlook for 2026 and 2027, suggests the company may be on track to achieve that target.

Another key highlight is the company’s move away from selling products under the licensed Maidenform brand and toward building its own branded platform. By owning the brand rather than licensing it, iFabric should gain greater control, improve margins, and create more opportunities to expand across products and markets.

The main concern in this press release relates to inventory clearance support provided in Q4 2025 to help major retailers transition from competing brands to iFabric-branded programs. This could have a meaningful impact on margins. We will need to monitor whether this support was a one-time transition expense or something that could become recurring.

iFabric Corp. designs and distributes apparel and develops and supplies performance textile treatments for clothing, medical, and protective fabric applications.

iFabric Corp. (IFABF) research, news, and more from GeoInvesting

Company description

Research